{"id":1704,"date":"2023-04-11T12:00:23","date_gmt":"2023-04-11T04:00:23","guid":{"rendered":"https:\/\/www.hanchorbio.com\/?post_type=news&#038;p=1704"},"modified":"2025-11-10T15:33:22","modified_gmt":"2025-11-10T07:33:22","slug":"hanchorbio-completes-the-face-to-face-scientific-advisory-board-meeting-2","status":"publish","type":"news","link":"https:\/\/www.hanchorbio.com\/en\/news\/hanchorbio-completes-the-face-to-face-scientific-advisory-board-meeting-2\/","title":{"rendered":"HanchorBio Completes the Face-to-Face Scientific Advisory Board Meeting"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-medicines, completed a face-to-face Scientific Advisory Board (SAB) meeting on March 29, 2023 in Taipei, Taiwan with world-renowned professors and few Board of Director (BOD) members.<\/p>\n","protected":false},"featured_media":0,"template":"","news-category":[],"class_list":["post-1704","news","type-news","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hanchorbio.com\/en\/wp-json\/wp\/v2\/news\/1704","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hanchorbio.com\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.hanchorbio.com\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/www.hanchorbio.com\/en\/wp-json\/wp\/v2\/media?parent=1704"}],"wp:term":[{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/www.hanchorbio.com\/en\/wp-json\/wp\/v2\/news-category?post=1704"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}